Abstract
(Abstracted from Gynecol Oncol 2021;161:46–55) Enhanced recovery after surgery (ERAS) pathways aim to reduce length of stay (LOS) and complications postoperatively and have demonstrated substantial benefit in these metrics across a wide range of surgical fields. Despite this evidence, the adoption of ERAS in gynecologic oncology on a global scale remains low, and some centers show minimal improvement in clinical outcomes after ERAS adoption.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
